Chimeric monoclonal antibodies, produced via genetic engineering of human antibody-producing cells (clones). For example, the genes coding for antilymphoma binding sites from a rat have been inserted into human antibody-producing cells to yield rat (antigen) binding sites mounted on human antibody “stems.”